CNTA Latest News, Press Relases and Analysis

All

Press Releases

14 days ago - By: Chartmill - Mentions: RIGL EVC TREX APPS ...

These stocks that are showing activity before the opening bell on Wednesday.

13 hours ago - By: The Motley Fool - Mentions: VKTX SKYE TRDA PHVS ...

5AM Venture Just Dumped Its Viking Stake—Smart Call or Missed Opportunity?

13 hours ago - By: The Motley Fool - Mentions: MLTX SKYE TRDA PHVS ...

5AM Venture Bails on MoonLake After a Brutal Year: Here’s What Stands Out

7 days ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals Announces Pricing of $250,000,000 Public Offering of American Depositary Shares

7 days ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals Announces Pricing of $250,000,000 Public Offering of American Depositary Shares

7 days ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals Announces Proposed Public Offering of American Depositary Shares

7 days ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals Announces Proposed Public Offering of American Depositary Shares

12 days ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

12 days ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

14 days ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2025 and Provides Update on Potential Best-in-Class Orexin Receptor 2 (OX2R) Agonist Program

14 days ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2025 and Provides Update on Potential Best-in-Class Orexin Receptor 2 (OX2R) Agonist Program

22 days ago - By: Benzinga - Mentions: AEE DPZ NP WEN

This Domino's Pizza Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

a month ago - By: Benzinga - Mentions: IBIO ABP AVR STTK ...

12 Health Care Stocks Moving In Monday's After-Market Session

3 months ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

3 months ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

3 months ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2025

3 months ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2025

4 months ago - By: Investor's Business Daily - Mentions: RY RY.CA ALKS TAK ...

Alkermes Offers The Next Proof Point For Its Narcolepsy Approach. Stock Dives.

5 months ago - By: Yahoo Finance - Mentions: AGEN HON ITGR TTEK ...

Agenus Inc. (AGEN) Surges After Zydus Agreement, Analysts Upbeat on Stock

5 months ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals Announces Clearance of Investigational New Drug Application (IND) for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist; Clinical Data in Acutely Sleep-Deprived Healthy Volunteers Planned for this Year

5 months ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals Announces Clearance of Investigational New Drug Application (IND) for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist; Clinical Data in Acutely Sleep-Deprived Healthy Volunteers Planned for this Year

6 months ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

6 months ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

6 months ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2025

6 months ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2025

7 months ago - By: Yahoo Finance - Mentions: GEHC IDYA BCYC EWTX ...

Here's Why GE HealthCare Stock Sank in April

7 months ago - By: Yahoo Finance - Mentions: XYLD JEPQ MTB

High-yield savings rates today: May 5, 2025 | APYs remain elevated despite a slight decline

7 months ago - By: Yahoo Finance - Mentions: DHI CMG

CENTESSA PHARMACEUTICALS-ADR (CNTA) Stock News

CNTA Latest News, Press Relases and Analysis

These stocks that are showing activity before the opening bell on Wednesday.

5AM Venture Just Dumped Its Viking Stake—Smart Call or Missed Opportunity?

5AM Venture Bails on MoonLake After a Brutal Year: Here’s What Stands Out

Centessa Pharmaceuticals Announces Pricing of $250,000,000 Public Offering of American Depositary Shares

Centessa Pharmaceuticals Announces Pricing of $250,000,000 Public Offering of American Depositary Shares

Centessa Pharmaceuticals Announces Proposed Public Offering of American Depositary Shares

Centessa Pharmaceuticals Announces Proposed Public Offering of American Depositary Shares

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

Centessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2025 and Provides Update on Potential Best-in-Class Orexin Receptor 2 (OX2R) Agonist Program

Centessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2025 and Provides Update on Potential Best-in-Class Orexin Receptor 2 (OX2R) Agonist Program

This Domino's Pizza Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

12 Health Care Stocks Moving In Monday's After-Market Session

Centessa Pharmaceuticals to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

Centessa Pharmaceuticals to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2025

Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2025

Alkermes Offers The Next Proof Point For Its Narcolepsy Approach. Stock Dives.

Agenus Inc. (AGEN) Surges After Zydus Agreement, Analysts Upbeat on Stock

Centessa Pharmaceuticals Announces Clearance of Investigational New Drug Application (IND) for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist; Clinical Data in Acutely Sleep-Deprived Healthy Volunteers Planned for this Year

Centessa Pharmaceuticals Announces Clearance of Investigational New Drug Application (IND) for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist; Clinical Data in Acutely Sleep-Deprived Healthy Volunteers Planned for this Year

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2025

Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2025

Here's Why GE HealthCare Stock Sank in April

High-yield savings rates today: May 5, 2025 | APYs remain elevated despite a slight decline

Is Centessa Pharmaceuticals plc (CNTA) the Best Small Cap Stock to Buy with the Biggest Upside Potential?